Pulmonary emphysema and tumor microenvironment in primary lung cancer

Journal of Surgical Research

Volumn 200, Issue 2, 2016, Pages 690-697

  Murakami, Junichi ^a   Ueda, Kazuhiro ^a   Sano, Fumiho ^a   Hayashi, Masataro ^a   Nishimoto, Arata ^a   Hamano, Kimikazu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Extracellular matrix; Lung cancer; Matrix metalloproteinases; Microenvironment; Pulmonary emphysema

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14; MMP14 PROTEIN, HUMAN; TUMOR MARKER;

AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CAPILLARY DENSITY; CELL PROLIFERATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG EMPHYSEMA; LUNG SURGERY; LYMPH VESSEL METASTASIS; MALE; NON SMALL CELL LUNG CANCER; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECURRENCE RISK; STROMA CELL; TUMOR MICROENVIRONMENT; ADULT; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; COMPLICATION; CYTOLOGY; ENZYMOLOGY; EVALUATION STUDY; FOLLOW UP; LUNG; LUNG NEOPLASMS; METABOLISM; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIOGRAPHY; RETROSPECTIVE STUDY; TUMOR INVASION; TUMOR RECURRENCE;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROVESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PULMONARY EMPHYSEMA; RETROSPECTIVE STUDIES; STROMAL CELLS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MICROENVIRONMENT;

EID: 85027957881     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.09.004     Document Type: Article

References (28)

1. Mishra, P., Banerjee, D., Ben-Baruch, A., Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy. J Leukoc Biol, 89, 2011, 31.
2. Ueda, K., Jinbo, M., Li, T.S., Yagi, T., Suga, K., Hamano, K., Computed tomography-diagnosed emphysema, not airway obstruction, is associated with the prognostic outcome of early-stage lung cancer. Clin Cancer Res, 12, 2006, 6730.
3. Ueda, K., Murakami, J., Sano, F., Hayashi, M., Suga, K., Hamano, K., Similar radiopathological features, but different postoperative recurrence rates, between stage I lung cancers arising in emphysematous lungs and those arising in nonemphysematous lungs. Eur J Cardiothorac Surg, 47, 2015, 905.
4. Mocchegiani, E., Giacconi, R., Costareli, L., Metalloproteases/anti-metalloproteases imbalance in chronic obstructive pulmonary disease: genetic factors and treatment implications. Curr Opin Pulm Med, 17, 2011, S11.
5. Demedts, I.K., Brusselle, G.G., Bracke, K.R., Vermaelen, K.Y., Pauwels, R.A., Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol, 5, 2005, 257.
6. Ishikawa, S., Takenaka, K., Yanagihara, K., et al. Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer. Clin Cancer Res, 10, 2004, 6579.
7. Oken, M.M., Creech, R.H., Tormey, D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol, 5, 1982, 649.
8. Fletcher, C.M., The clinical diagnosis of pulmonary emphysema; an experimental study. Proc R Soc Med, 45, 1952, 577.
9. Park, K.J., Bergin, C.J., Clausen, J.L., Quantitation of emphysema with three-dimensional CT densitometry: comparison with two-dimensional analysis, visual emphysema scores, and pulmonary function test results. Radiology, 211, 1999, 541.
10. Knudson, R.J., Standen, J.R., Kaltenborn, W.T., et al. Expiratory computed tomography for assessment of suspected pulmonary emphysema. Chest, 99, 1991, 1357.
11. Shao, W., Wang, W., Xiong, X.G., et al. Prognostic impact of MMP-2 and MMP-9 expression in pathologic stage IA non-small cell lung cancer. J Surg Oncol, 104, 2011, 841.
12. Takase, Y., Kai, K., Masuda, M., Akashi, M., Tokunaga, O., Endoglin (CD105) expression and angiogenesis status in small cell lung cancer. Pathol Res Pract, 206, 2010, 725.
13. Tanaka, F., Otake, Y., Yanagihara, K., et al. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD05 antibody. Clin Cancer Res, 7, 2001, 3410.
14. Bodas, M., Tran, I., Vij, N., Therapeutic strategies to correct proteostasis-imbalance in chronic obstructive lung disease. Curr Mol Med, 12, 2012, 807.
15. Sekine, Y., Hara, A., Koh, E., Hiroshima, K., Lung carcinogenesis from chronic obstructive pulmonary disease: characteristics of lung cancer from COPD and contribution of signal transducers and lung stem cells in the inflammatory microenvironment. Gen Thorac Cardiovasc Surg, 62, 2014, 415.
16. Kishi, K., Gurney, J.W., Schroeder, D.R., Scanlon, P.D., Swensen, S.J., Jett, J.R., The correlation of emphysema or airway obstruction with the risk of lung cancer: a matched case-controlled study. Eur Respir J, 19, 2002, 1093.
17. de Torres, J.P., Bastarrika, G., Wisnivesky, J.P., et al. Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest, 132, 2007, 1932.
18. Gross, J., Lapiere, C.M., Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA, 48, 1962, 1014.
19. Page-McCaw, A., Ewald, A.J., Werb, Z., Matrix metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol, 8, 2007, 221.
20. Grigioni, W.F., Garbisa, S., D'Errico, A., et al. Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens. Am J Pathol, 138, 1991, 647.
21. Levy, A.T., Cioce, V., Sobel, M.E., et al. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res, 51, 1991, 439.
22. Jodele, S., Blavier, L., Yoon, J.M., DeClerck, Y.A., Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev, 25, 2006, 35.
23. Wolf, K., Mazo, I., Leung, H., et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol, 160, 2003, 267.
24. Foronjy, R., Mkyimbeng, T., Wallance, A., et al. Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin. Am J Physiol Lung Cell Mol Physiol, 294, 2008, 1149.
25. Bonniaud, P., Kolb, M., Galt, T., et al. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol, 173, 2004, 2099.
26. Chen, H., Sun, J., Buckley, S., et al. Abnormal mouse lung alveolarization caused by Smad3 deficiency is a developmental antecedent of centrilobular emphysema. Am J Physiol Lung Cell Mol Physiol, 288, 2005, 683.
27. Zucker, S., Cao, J., Chen, W.T., Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene, 19, 2000, 6642.
28. Chen, M.H., Cui, S.X., Cheng, Y.N., et al. Galloyl cyclic-imide derivative CH1104I inhibits tumor invasion through suppressing matrix metalloproteinase activity. Anticancer Drugs, 19, 2008, 957.